Please login to the form below

Not currently logged in


This page shows the latest anti-cholesterol news and features for those working in and with pharma, biotech and healthcare.

NICE backs use of anti-cholesterol drug Ezetrol

NICE backs use of anti-cholesterol drug Ezetrol

Draft guidance reflects 'greater emphasis on managing CVD risk'. NICE has recommended Merck Sharp &Dohme's cholesterol drug Ezetrol (ezetimibe) in draft guidance. ... In this way Ezetrol can be combined with statins to provide a complementary or

Latest news

  • FDA approves four new medicines across multiple areas FDA approves four new medicines across multiple areas

    Sanofi/Regeneron, BMS, AbbVie and Novartis all chalk up major approvals.  . The FDA has given the green light to four major new treatments for skin cancer, patients with high cholesterol and ... First up, Sanofi and Regeneron's eagerly anticipated

  • Sanofi and Regeneron pay $67.5m to speed alirocumab review Sanofi and Regeneron pay $67.5m to speed alirocumab review

    Buy FDA priority review voucher from BioMarin.  . Sanofi and Regeneron Pharmaceuticals are paying $67.5m for an unusual licence which could enable them to get anti-cholesterol product alirocumab onto the

  • Amgen profits down on rising costs Amgen profits down on rising costs

    Broadway pointed to the start of phase III trials for four new projects in 2012, namely anti-cholesterol antibody AMG-145, romosuzamab for osteoporosis, brodalumab for psoriasis and rilotumamab for gastric

  • Philippines forces drug price cuts

    The mandatory 50 per cent price cuts will cover the anti-hypertensive amlodipine, the antibiotic azithromycin, cholesterol-lowering atorvastatin and two cancer treatments – doxorubicin and cytarabine.

  • Pharma news in brief

    The move is the latest effort by the German manufacturer to reduce costs and streamline its pharma business which has been hit by problems since the costly recall of anti-cholesterol

More from news
Approximately 0 fully matching, plus 21 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...